Alkil-pyridines as 11-beta inhibitors for diabetes

Details for Australian Patent Application No. 2005291561 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Amrein, Kurt; Hunziker, Daniel; Mayweg, Alexander; Kuhn, Bernd; Neidhart, Werner

Agent Spruson & Ferguson

Pub. Number AU-B-2005291561

PCT Pub. Number WO2006/037501

Priority 04104856.2 04.10.04 EP

Filing date 26 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 25 February 2010

International Classifications

C07D 213/76 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/037501 Priority application(s): WO2006/037501

25 February 2010 Application Accepted

  Published as AU-B-2005291561

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005291575-Peelable child-resistant packaging for wafer pharmaceutical forms

2005291557-Tantalum powder for the production of solid electrolyte capacitors